329 related articles for article (PubMed ID: 21069419)
1. Osteoclastogenesis and arthritis.
Maruotti N; Grano M; Colucci S; d'Onofrio F; Cantatore FP
Clin Exp Med; 2011 Sep; 11(3):137-45. PubMed ID: 21069419
[TBL] [Abstract][Full Text] [Related]
2. Why TNF-α inhibition is not sufficient to avoid juxta-articular erosions in chronic arthritis?
Maruotti N; d'Onofrio F; Corrado A; Cantatore FP
Intern Emerg Med; 2012 Feb; 7(1):15-20. PubMed ID: 21298362
[TBL] [Abstract][Full Text] [Related]
3. RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation.
Danks L; Komatsu N; Guerrini MM; Sawa S; Armaka M; Kollias G; Nakashima T; Takayanagi H
Ann Rheum Dis; 2016 Jun; 75(6):1187-95. PubMed ID: 26025971
[TBL] [Abstract][Full Text] [Related]
4. Bone and joint destruction in rheumatoid arthritis: what is really happening?
Goldring SR
J Rheumatol Suppl; 2002 Sep; 65():44-8. PubMed ID: 12236623
[TBL] [Abstract][Full Text] [Related]
5. Total Saponin from Anemone flaccida Fr. Schmidt Prevents Bone Destruction in Experimental Rheumatoid Arthritis via Inhibiting Osteoclastogenesis.
Liu C; Yang Y; Sun D; Wang C; Wang H; Jia S; Liu L; Lin N
Rejuvenation Res; 2015 Dec; 18(6):528-42. PubMed ID: 26418168
[TBL] [Abstract][Full Text] [Related]
6. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis.
Romas E; Gillespie MT; Martin TJ
Bone; 2002 Feb; 30(2):340-6. PubMed ID: 11856640
[TBL] [Abstract][Full Text] [Related]
7. Adipokines in psoriatic arthritis patients: the correlations with osteoclast precursors and bone erosions.
Xue Y; Jiang L; Cheng Q; Chen H; Yu Y; Lin Y; Yang X; Kong N; Zhu X; Xu X; Wan W; Zou H
PLoS One; 2012; 7(10):e46740. PubMed ID: 23144698
[TBL] [Abstract][Full Text] [Related]
8. Psoriatic cutaneous inflammation promotes human monocyte differentiation into active osteoclasts, facilitating bone damage.
Raimondo A; Lembo S; Di Caprio R; Donnarumma G; Monfrecola G; Balato N; Ayala F; Balato A
Eur J Immunol; 2017 Jun; 47(6):1062-1074. PubMed ID: 28386999
[TBL] [Abstract][Full Text] [Related]
9. Osteoclast differentiation in rheumatoid arthritis.
Yokota K
Immunol Med; 2024 Mar; 47(1):6-11. PubMed ID: 37309864
[TBL] [Abstract][Full Text] [Related]
10. Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis.
Colucci S; Brunetti G; Cantatore FP; Oranger A; Mori G; Quarta L; Cirulli N; Mancini L; Corrado A; Grassi FR; Grano M
J Pathol; 2007 May; 212(1):47-55. PubMed ID: 17370327
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis.
Wong PK; Quinn JM; Sims NA; van Nieuwenhuijze A; Campbell IK; Wicks IP
Arthritis Rheum; 2006 Jan; 54(1):158-68. PubMed ID: 16385511
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1.
Jin YR; Stohn JP; Wang Q; Nagano K; Baron R; Bouxsein ML; Rosen CJ; Adarichev VA; Lindner V
Bone; 2017 Apr; 97():153-167. PubMed ID: 28115279
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of sorting nexin 10 prevents bone erosion in collagen-induced mouse arthritis through promoting NFATc1 degradation.
Zhou C; You Y; Shen W; Zhu YZ; Peng J; Feng HT; Wang Y; Li D; Shao WW; Li CX; Li WZ; Xu J; Shen X
Ann Rheum Dis; 2016 Jun; 75(6):1211-8. PubMed ID: 26141367
[TBL] [Abstract][Full Text] [Related]
14. Alisol-B, a novel phyto-steroid, suppresses the RANKL-induced osteoclast formation and prevents bone loss in mice.
Lee JW; Kobayashi Y; Nakamichi Y; Udagawa N; Takahashi N; Im NK; Seo HJ; Jeon WB; Yonezawa T; Cha BY; Woo JT
Biochem Pharmacol; 2010 Aug; 80(3):352-61. PubMed ID: 20412788
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid Receptor 2 Agonist Prevents Local and Systemic Inflammatory Bone Destruction in Rheumatoid Arthritis.
Zhu M; Yu B; Bai J; Wang X; Guo X; Liu Y; Lin J; Hu S; Zhang W; Tao Y; Hu C; Yang H; Xu Y; Geng D
J Bone Miner Res; 2019 Apr; 34(4):739-751. PubMed ID: 30508319
[TBL] [Abstract][Full Text] [Related]
16. RANK, RANKL and osteoprotegerin in arthritic bone loss.
Bezerra MC; Carvalho JF; Prokopowitsch AS; Pereira RM
Braz J Med Biol Res; 2005 Feb; 38(2):161-70. PubMed ID: 15785827
[TBL] [Abstract][Full Text] [Related]
17. Depth and volume of resorption induced by osteoclasts generated in the presence of RANKL, TNF-alpha/IL-1 or LIGHT.
Mabilleau G; Pascaretti-Grizon F; Baslé MF; Chappard D
Cytokine; 2012 Feb; 57(2):294-9. PubMed ID: 22172512
[TBL] [Abstract][Full Text] [Related]
18. RANK-Independent Osteoclast Formation and Bone Erosion in Inflammatory Arthritis.
O'Brien W; Fissel BM; Maeda Y; Yan J; Ge X; Gravallese EM; Aliprantis AO; Charles JF
Arthritis Rheumatol; 2016 Dec; 68(12):2889-2900. PubMed ID: 27563728
[TBL] [Abstract][Full Text] [Related]
19. Joint erosion in rheumatoid arthritis: interactions between tumour necrosis factor alpha, interleukin 1, and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclasts.
O' Gradaigh D; Ireland D; Bord S; Compston JE
Ann Rheum Dis; 2004 Apr; 63(4):354-9. PubMed ID: 15020327
[TBL] [Abstract][Full Text] [Related]
20. Activation of p38 MAPK is a key step in tumor necrosis factor-mediated inflammatory bone destruction.
Zwerina J; Hayer S; Redlich K; Bobacz K; Kollias G; Smolen JS; Schett G
Arthritis Rheum; 2006 Feb; 54(2):463-72. PubMed ID: 16447221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
